this issue
previous article in this issuenext article in this issue

Document Details :

Title: Targeted therapy for metastatic renal cell cancer
Author(s): VERBAEYS C, HOEBEKE P, VAN BELLE S, ROTTEY S
Journal: Acta Clinica Belgica
Volume: 65    Issue: 2   Date: 2010   
Pages: 115-121
DOI: 10.2143/ACB.65.2.1002395

Abstract :






Renal cell cancer is a common urological malignancy for which the incidence has doubled over the last three decades. Thirty percent of patients have metastatic disease at the moment of diagnosis. Thirty percent of the remaining surgically treated patients will develop metastases. Before the introduction of targeted therapies the only therapeutic option for these patients was immunotherapy with bad tolerability and poor results. This review discusses these new ‘targeted therapies’.